Nikolaos Pistamaltzian

Author

National and Kapodistrian University of Athens

Also Known As

N. F. Pistamaltzian, N. Pistamaltzian, N.F. Pistamaltzian, Nikolaos F Pistamaltzian, Nikolaos F. Pistamaltzian, Nikolaos Fragkiskos Pistamaltzian, Nikolaos Pistamaltzian

Publications

290

Citations

H-Index

Concepts

All Affiliations

National and Kapodistrian University of Athens St Savas Hospital Mitera Hospital The University of Texas MD Anderson Cancer Center Brooke Army Medical Center

About

Nikolaos Pistamaltzian is an author at National and Kapodistrian University of Athens specializing in medicine, oncology, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	176
2	Immunology	3	3	132
3	Cell Biology	1	1	13
4	Pathology	1	1	12
5	Pharmacology	1	1	25

Nikolaos Pistamaltzian

Publications

269

Citations

H-Index

Page 1

	Year	Citations
Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide AE37 vaccine in breast cancer patients to prevent recurrence Elizabeth A. Mittendorf, Alexandros Ardavanis, James T. Symanowski, Annals of Oncology VaccinationBreast OncologyBreast Cancer PatientsMedicineImmunology	2016	107
Prospective, randomized, single-blinded, multi-center phase II trial of two HER2 peptide vaccines, GP2 and AE37, in breast cancer patients to prevent recurrence Tommy A. Brown, Elizabeth A. Mittendorf, Diane F. Hale, Breast Cancer Research and Treatment	2020	75
Weekly Paclitaxel and Carboplatin Plus Bevacizumab as First-Line Treatment of Metastatic Triple-Negative Breast Cancer. A Multicenter Phase II Trial by the Hellenic Oncology Research Group Emmanouil Saloustros, Michail Nikolaou, K. Kalbakis, Clinical Breast Cancer Breast OncologyOncologyMedicineWeekly PaclitaxelBreast Cancer	2017	25
Treatment of relapsed urothelial bladder cancer with vinflunine Nikolaos Pistamaltzian, Kimon Tzannis, Vassiliki Pissanidou, Anti-Cancer Drugs UrologyGenitourinary CancerUrothelial CancerMedicineCancer Management	2015	19
The Impact of Thromboprophylaxis on the Survival of Patients with Advanced Pancreatic Cancer. The Pancreatic Cancer and Tinzaparin (PaCT) Study Michalis V. Karamouzis, Ilias Athanasiadis, G.F. Samelis, Cancers	2021	18
Ovarian malignant ascites-derived lymphocytes stimulated with prothymosin α or its immunoactive decapeptide lyse autologous tumour cells in vitro and retard tumour growth in SCID mice Ioannis F. Voutsas, Nikolaos Pistamaltzian, Marinos Tsiatas, European Journal of Cancer Tumour GrowthMedicineImmunologyCancer Cell BiologyProthymosin α	2012	13
Subgroup efficacy evaluation of the AE37 HER2 vaccine in breast cancer patients in the adjuvant setting. Kaitlin M. Peace, Elizabeth A. Mittendorf, Sonia A. Perez, Journal of Clinical Oncology Breast OncologyImmunologyAe37 VaccinePathologyImmunodominance	2017	12

Page 1